Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2026-06-30 @ 1:39 PM
Study NCT ID:
NCT01761266
Status:
COMPLETED
Last Update Posted:
2022-04-05
First Post:
2013-01-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma
Sponsor:
Organization: